Beckwith-Wiedemann Syndrome
6
3
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks
Body Perception and Representation in Overgrowth Syndromes, Behavioral Assessment and Neuropsychological Development